NanoViricides, Inc. (NNVC) Financials

NNVC Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 13.4 million 951074
2023-09-30 16.9 million 2.0 million
2023-06-30 16.9 million 2.0 million
2023-03-31 18.6 million 348744

NNVC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -1.7 million 47608
2023-09-30 -1.5 million 50455
2023-06-30 -1.5 million 50455
2023-03-31 -1.8 million 60305

NNVC Net Income

No data available :(

NNVC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 5.2 million - -
2023-09-30 8.1 million - -
2023-06-30 - - -
2023-03-31 9.7 million - -

NNVC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 11.7 million
2023-09-30 11.6 million
2023-06-30 11.7 million
2023-03-31 11.6 million

NNVC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 5474 1.6 million 610877 -189330
2023-09-30 2566 2.9 million 763422 -
2023-06-30 2566 2.9 million 763422 -
2023-03-31 59301 1.2 million 614647 -

NNVC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 189330
2023-09-30 - 188882
2023-06-30 - -
2023-03-31 - 188322

NNVC

Price: $1.13

52 week price:
1.00
2.00

Earnings Per Share: -0.80 USD

P/E Ratio: -1.52

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Volume: 10400

Market Capitalization: 13.4 million

Links: